Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis

NCT00456092 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

DRUG: Apremilast
DRUG: Placebo

Sponsor

Amgen